ArticleEntropy (Basel, Switzerland)2025
A Bayesian Model for Paired Data in Genome-Wide Association Studies with Application to Breast Cancer.
Article in Entropy (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Complex human diseases, including cancer, are linked to genetic factors. Genome-wide association studies (GWASs) are powerful for identifying genetic variants associated with cancer but are limited by their reliance on case-control data. We propose approaches to expanding GWAS by using tumor and paired normal tissues to investigate somatic mutations. We apply penalized maximum likelihood estimation for single-marker analysis and develop a Bayesian hierarchical model to integrate multiple markers, identifying SNP sets grouped by genes or pathways, improving detection of moderate-effect SNPs. Applied to breast cancer data from The Cancer Genome Atlas (TCGA), both single- and multiple-marker analyses identify associated genes, with multiple-marker analysis providing more consistent results with external resources. The Bayesian model significantly increases the chance of new discoveries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.